Capital Analysts, LLC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1624758
FORT WASHINGTON, PA
Position in VRTX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$53,137
+$548 QoQ
Shares Held
119
+2.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Capital Analysts, LLC holds $1,026,985 across 15 Biotechnology names. VRTX ranks #3 (5.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
9,179 | $466,292 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
520 | $401,772 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
119 | $53,137 | |
| 4 | FTRE |
Fortrea Holdings Inc.
|
2,788 | $26,262 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
446 | $25,194 | |
| 6 | OMER |
Omeros Corp
|
1,000 | $10,560 | |
| 7 | SPRY |
ARS Pharmaceuticals, Inc.
|
1,300 | $10,439 | |
| 8 | VRCA |
Verrica Pharmaceuticals Inc.
|
1,500 | $7,935 |
All Filings in VRTX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $53,137 | 119 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $52,589 | 116 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $45,429 | 116 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $38,732 | 87 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $42,179 | 87 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $31,007 | 77 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $37,206 | 80 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $37,497 | 80 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $32,186 | 77 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $31,330 | 77 | Shares | Defined | 2024-01-30 | |
| 2023-09-30 | $26,775 | 77 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $27,097 | 77 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $24,260 | 77 | Shares | Defined | 2023-05-05 | |
| 2022-12-31 | $22,236 | 77 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $27,795 | 96 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $21,697 | 77 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $20,094 | 77 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $16,909 | 77 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $13,967 | 77 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $15,525 | 77 | Shares | Defined | 2021-11-15 | |
| 2021-03-31 | $16,546 | 77 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $18,198 | 77 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $20,953 | 77 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $22,353 | 77 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $18,322 | 77 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||